Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018422
Filing Date
2023-11-09
Accepted
2023-11-09 07:47:03
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20230930x10q.htm   iXBRL 10-Q 2382278
2 EX-31.1 aplt-20230930xex31d1.htm EX-31.1 13017
3 EX-31.2 aplt-20230930xex31d2.htm EX-31.2 13102
4 EX-32.1 aplt-20230930xex32d1.htm EX-32.1 5839
5 EX-32.2 aplt-20230930xex32d2.htm EX-32.2 5982
  Complete submission text file 0001558370-23-018422.txt   10073214

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20230930.xsd EX-101.SCH 76729
7 EX-101.CAL aplt-20230930_cal.xml EX-101.CAL 54193
8 EX-101.DEF aplt-20230930_def.xml EX-101.DEF 321030
9 EX-101.LAB aplt-20230930_lab.xml EX-101.LAB 577008
10 EX-101.PRE aplt-20230930_pre.xml EX-101.PRE 543291
88 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20230930x10q_htm.xml XML 1696160
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 231390109
SIC: 2834 Pharmaceutical Preparations